Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Vasoinhibin generation and effect on neuronal apoptosis in the hippocampus of late mouse embryos.

Aroña RM, Arnold E, Macías F, López-Casillas F, Clapp C, Martínez de la Escalera G.

Am J Physiol Regul Integr Comp Physiol. 2020 Apr 1;318(4):R760-R771. doi: 10.1152/ajpregu.00286.2019. Epub 2020 Feb 12.

PMID:
32048872
2.

Structural Adaptation in Its Orphan Domain Engenders Betaglycan with an Alternate Mode of Growth Factor Binding Relative to Endoglin.

Kim SK, Whitley MJ, Krzysiak TC, Hinck CS, Taylor AB, Zwieb C, Byeon CH, Zhou X, Mendoza V, López-Casillas F, Furey W, Hinck AP.

Structure. 2019 Sep 3;27(9):1427-1442.e4. doi: 10.1016/j.str.2019.06.010. Epub 2019 Jul 18.

PMID:
31327662
3.

Unravelling the modus-operandi of chromenylium-cyanine fluorescent probes: a case study.

Flores-Cruz R, López-Arteaga R, Ramírez-Vidal L, López-Casillas F, Jiménez-Sánchez A.

Phys Chem Chem Phys. 2019 Jul 17;21(28):15779-15786. doi: 10.1039/c9cp03256h.

PMID:
31282523
4.

Vasoinhibin Suppresses Nerve Growth Factor-Induced Differentiation and Survival of PC12 Pheochromocytoma Cells.

Melo Z, Castillo X, Moreno-Carranza B, Ledesma-Colunga MG, Arnold E, López-Casillas F, Ruíz-Herrera X, Clapp C, Martínez de la Escalera G.

Neuroendocrinology. 2019;109(2):152-164. doi: 10.1159/000499507. Epub 2019 May 15.

PMID:
31091528
5.

Author Correction: Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.

Arredondo Zamarripa D, Noguez Imm R, Bautista Cortés AM, Vázquez Ruíz O, Bernardini M, Fiorio Pla A, Gkika D, Prevarskaya N, López-Casillas F, Liedtke W, Clapp C, Thébault S.

Sci Rep. 2018 Jun 20;8(1):9652. doi: 10.1038/s41598-018-27642-4.

6.

TβRIII is induced by TCR signaling and downregulated in FoxP3+ regulatory T cells.

Ortega-Francisco S, de la Fuente-Granada M, Alvarez Salazar EK, Bolaños-Castro LA, Fonseca-Camarillo G, Olguin-Alor R, Alemán-Muench GR, López-Casillas F, Raman C, García-Zepeda EA, Soldevila G.

Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):82-87. doi: 10.1016/j.bbrc.2017.10.081. Epub 2017 Oct 16.

PMID:
29050936
7.

Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.

Arredondo Zamarripa D, Noguez Imm R, Bautista Cortés AM, Vázquez Ruíz O, Bernardini M, Fiorio Pla A, Gkika D, Prevarskaya N, López-Casillas F, Liedtke W, Clapp C, Thébault S.

Sci Rep. 2017 Oct 12;7(1):13094. doi: 10.1038/s41598-017-13621-8. Erratum in: Sci Rep. 2018 Jun 20;8(1):9652.

8.

Correction to Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.

Villarreal MM, Kim SK, Barron L, Kodali R, Baardsnes J, Hinck CS, Krzysiak TC, Henen MA, Pakhomova O, Mendoza V, O'Connor-McCourt MD, Lafer EM, López-Casillas F, Hinck AP.

Biochemistry. 2017 Jul 18;56(28):3689. doi: 10.1021/acs.biochem.7b00566. Epub 2017 Jul 5. No abstract available.

PMID:
28677957
9.

Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.

Villarreal MM, Kim SK, Barron L, Kodali R, Baardsnes J, Hinck CS, Krzysiak TC, Henen MA, Pakhomova O, Mendoza V, O'Connor-McCourt MD, Lafer EM, López-Casillas F, Hinck AP.

Biochemistry. 2016 Dec 13;55(49):6880-6896. Epub 2016 Dec 2. Erratum in: Biochemistry. 2017 Jul 18;56(28):3689.

10.

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos.

Molina-Villa T, Mendoza V, López-Casillas F.

J Vis Exp. 2016 Aug 31;(114). doi: 10.3791/54405.

11.

Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis.

Ramos-Espinosa O, Hernández-Bazán S, Francisco-Cruz A, Mata-Espinosa D, Barrios-Payán J, Marquina-Castillo B, López-Casillas F, Carretero M, Del Río M, Hernández-Pando R.

Pathog Dis. 2016 Oct;74(7). pii: ftw075. doi: 10.1093/femspd/ftw075. Epub 2016 Sep 7.

PMID:
27604468
12.

Betaglycan knock-down causes embryonic angiogenesis defects in zebrafish.

Kamaid A, Molina-Villa T, Mendoza V, Pujades C, Maldonado E, Ispizua Belmonte JC, López-Casillas F.

Genesis. 2015 Sep;53(9):583-603. doi: 10.1002/dvg.22876. Epub 2015 Aug 21.

PMID:
26174808
13.

Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics.

Delolme F, Anastasi C, Alcaraz LB, Mendoza V, Vadon-Le Goff S, Talantikite M, Capomaccio R, Mevaere J, Fortin L, Mazzocut D, Damour O, Zanella-Cléon I, Hulmes DJ, Overall CM, Valcourt U, Lopez-Casillas F, Moali C.

Cell Mol Life Sci. 2015 Mar;72(5):1009-27. doi: 10.1007/s00018-014-1733-x. Epub 2014 Sep 27.

PMID:
25260970
14.

Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis.

Aleman-Muench GR, Mendoza V, Stenvers K, Garcia-Zepeda EA, Lopez-Casillas F, Raman C, Soldevila G.

PLoS One. 2012;7(8):e44217. doi: 10.1371/journal.pone.0044217. Epub 2012 Aug 29.

16.

TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Huang T, David L, Mendoza V, Yang Y, Villarreal M, De K, Sun L, Fang X, López-Casillas F, Wrana JL, Hinck AP.

EMBO J. 2011 Apr 6;30(7):1263-76. doi: 10.1038/emboj.2011.54. Epub 2011 Mar 18.

17.

Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.

Mendoza V, Vilchis-Landeros MM, Mendoza-Hernández G, Huang T, Villarreal MM, Hinck AP, López-Casillas F, Montiel JL.

Biochemistry. 2009 Dec 15;48(49):11755-65. doi: 10.1021/bi901528w.

18.

Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis.

Mata-Espinosa DA, Mendoza-Rodríguez V, Aguilar-León D, Rosales R, López-Casillas F, Hernández-Pando R.

Mol Ther. 2008 Jun;16(6):1065-1072. doi: 10.1038/mt.2008.69. Epub 2016 Dec 8.

PMID:
28178470
19.

Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.

García C, Aranda J, Arnold E, Thébault S, Macotela Y, López-Casillas F, Mendoza V, Quiroz-Mercado H, Hernández-Montiel HL, Lin SH, de la Escalera GM, Clapp C.

J Clin Invest. 2008 Jun;118(6):2291-300. doi: 10.1172/JCI34508.

20.

Therapeutic effect of recombinant adenovirus encoding interferon-gamma in a murine model of progressive pulmonary tuberculosis.

Mata-Espinosa DA, Mendoza-Rodríguez V, Aguilar-León D, Rosales R, López-Casillas F, Hernández-Pando R.

Mol Ther. 2008 Jun;16(6):1065-72. doi: 10.1038/mt.2008.69. Epub 2008 Apr 22.

21.

A new highly effective anticysticercosis vaccine expressed in transgenic papaya.

Hernández M, Cabrera-Ponce JL, Fragoso G, López-Casillas F, Guevara-García A, Rosas G, León-Ramírez C, Juárez P, Sánchez-García G, Cervantes J, Acero G, Toledo A, Cruz C, Bojalil R, Herrera-Estrella L, Sciutto E.

Vaccine. 2007 May 22;25(21):4252-60. Epub 2007 Mar 16.

PMID:
17399859
22.

Soluble betaglycan reduces renal damage progression in db/db mice.

Juárez P, Vilchis-Landeros MM, Ponce-Coria J, Mendoza V, Hernández-Pando R, Bobadilla NA, López-Casillas F.

Am J Physiol Renal Physiol. 2007 Jan;292(1):F321-9. Epub 2006 Sep 5.

23.

Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by non-specific enhanced immunity.

Cruz-Revilla C, Sonabend AM, Rosas G, Toledo A, Meneses G, Lopez-Casillas F, Hernández B, Fragoso G, Sciutto E.

J Parasitol. 2006 Jun;92(3):655-7.

PMID:
16884018
24.

A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Hernández-Pando R, Orozco-Esteves H, Maldonado HA, Aguilar-León D, Vilchis-Landeros MM, Mata-Espinosa DA, Mendoza V, López-Casillas F.

Clin Exp Immunol. 2006 May;144(2):264-72.

25.

Transforming growth factor beta inhibits proliferation of somatic cells without influencing germ cell number in the chicken embryonic ovary.

Méndez C, Alcántara L, Escalona R, López-Casillas F, Pedernera E.

Cell Tissue Res. 2006 Jul;325(1):143-9. Epub 2006 Mar 9.

PMID:
16525833
26.

Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor.

De Crescenzo G, Hinck CS, Shu Z, Zúñiga J, Yang J, Tang Y, Baardsnes J, Mendoza V, Sun L, López-Casillas F, O'Connor-McCourt M, Hinck AP.

J Mol Biol. 2006 Jan 6;355(1):47-62. Epub 2005 Nov 2. Erratum in: J Mol Biol. 2006 Jun 2;359(2):508.

PMID:
16300789
27.

Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.

Zúñiga JE, Groppe JC, Cui Y, Hinck CS, Contreras-Shannon V, Pakhomova ON, Yang J, Tang Y, Mendoza V, López-Casillas F, Sun L, Hinck AP.

J Mol Biol. 2005 Dec 16;354(5):1052-68. Epub 2005 Oct 27.

PMID:
16289576
28.
29.

Amplified expression of dominant-negative transforming growth factor-beta type II receptor inhibits collagen type I production via reduced Smad-3 activity.

Hernandez-Cañaveral I, González J, López-Casillas F, Armendariz-Borunda J.

J Gastroenterol Hepatol. 2004 Apr;19(4):380-7.

PMID:
15012774
30.

The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.

Velasco-Loyden G, Arribas J, López-Casillas F.

J Biol Chem. 2004 Feb 27;279(9):7721-33. Epub 2003 Dec 12.

31.

[Receptors and functions of TGF-beta, a crucial cytokine in wound healing].

García-Sainz JA, Vilchis-Landeros MM, Juárez P, López-Casillas F, Hernández-Pando R, Massagué J.

Gac Med Mex. 2003 Mar-Apr;139(2):126-43. Spanish. No abstract available.

PMID:
12754948
32.

Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.

Feria I, Pichardo I, Juárez P, Ramírez V, González MA, Uribe N, García-Torres R, López-Casillas F, Gamba G, Bobadilla NA.

Kidney Int. 2003 Jan;63(1):43-52.

33.

Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta.

Lopez-Casillas F, Riquelme C, Perez-Kato Y, Ponce-Castaneda MV, Osses N, Esparza-Lopez J, Gonzalez-Nunez G, Cabello-Verrugio C, Mendoza V, Troncoso V, Brandan E.

J Biol Chem. 2003 Jan 3;278(1):382-90. Epub 2002 Oct 23.

34.

New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis.

Sciutto E, Fragoso G, Manoutcharian K, Gevorkian G, Rosas-Salgado G, Hernández-Gonzalez M, Herrera-Estrella L, Cabrera-Ponce J, López-Casillas F, González-Bonilla C, Santiago-Machuca A, Ruíz-Pérez F, Sánchez J, Goldbaum F, Aluja A, Larralde C.

Arch Med Res. 2002 Jul-Aug;33(4):371-8. Review.

PMID:
12234527
35.

Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.

Bandyopadhyay A, López-Casillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun LZ.

Cancer Res. 2002 Aug 15;62(16):4690-5.

36.

Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in pancreatic MIN6 beta-cells.

Andreolas C, da Silva Xavier G, Diraison F, Zhao C, Varadi A, Lopez-Casillas F, Ferré P, Foufelle F, Rutter GA.

Diabetes. 2002 Aug;51(8):2536-45.

37.

Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells.

Bandyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, López-Casillas F, Sun LZ.

Oncogene. 2002 May 16;21(22):3541-51.

38.

p32 (gC1qBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in ray hepatocytes.

Robles-Flores M, Rendon-Huerta E, Gonzalez-Aguilar H, Mendoza-Hernandez G, Islas S, Mendoza V, Ponce-Castaneda MV, Gonzalez-Mariscal L, Lopez-Casillas F.

J Biol Chem. 2002 Feb 15;277(7):5247-55. Epub 2001 Nov 6.

39.

[Repeated elements in the human genome: junk DNA or genomic treasure?].

López-Casillas F, Ponce-Castañeda MV.

Rev Invest Clin. 2001 Jul-Aug;53(4):302-7. Spanish. No abstract available.

PMID:
11599475
40.

Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, López-Casillas F.

J Biol Chem. 2001 May 4;276(18):14588-96. Epub 2001 Feb 5.

41.

Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent.

Vilchis-Landeros MM, Montiel JL, Mendoza V, Mendoza-Hernández G, López-Casillas F.

Biochem J. 2001 Apr 1;355(Pt 1):215-22.

42.

[Transforming growth factor-beta (TGF-beta), keystone in diabetic nephropathy].

López-Casillas F.

Rev Invest Clin. 2000 Sep-Oct;52(5):487-90. Review. Spanish. No abstract available.

PMID:
11195175
43.

Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.

Toledo A, Fragoso G, Rosas G, Hernández M, Gevorkian G, López-Casillas F, Hernández B, Acero G, Huerta M, Larralde C, Sciutto E.

Infect Immun. 2001 Mar;69(3):1766-73.

44.

Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization.

Cruz-Revilla C, Rosas G, Fragoso G, López-Casillas F, Toledo A, Larralde C, Sciutto E.

J Parasitol. 2000 Feb;86(1):67-74.

PMID:
10701566
45.

Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.

Toledo A, Larralde C, Fragoso G, Gevorkian G, Manoutcharian K, Hernández M, Acero G, Rosas G, López-Casillas F, Garfias CK, Vázquez R, Terrazas I, Sciutto E.

Infect Immun. 1999 May;67(5):2522-30.

46.

Murine betaglycan primary structure, expression and glycosaminoglycan attachment sites.

Ponce-Castañeda MV, Esparza-López J, Vilchis-Landeros MM, Mendoza V, López-Casillas F.

Biochim Biophys Acta. 1998 May 19;1384(2):189-96.

PMID:
9659379
47.

Taenia crassiceps cysticercosis: humoral immune response and protection elicited by DNA immunization.

Rosas G, Cruz-Revilla C, Fragoso G, López-Casillas F, Pérez A, Bonilla MA, Rosales R, Sciutto E.

J Parasitol. 1998 Jun;84(3):516-23.

PMID:
9645849
49.

TGF-beta receptors and actions.

Attisano L, Wrana JL, López-Casillas F, Massagué J.

Biochim Biophys Acta. 1994 May 26;1222(1):71-80. Review. No abstract available.

PMID:
8186268
50.

Supplemental Content

Loading ...
Support Center